468741-20-0 Usage
Description
2-METHYL-4-MORPHOLINO-6-NITROANILINE is a nitroaniline derivative chemical compound with the molecular formula C11H14N4O3. It features a methyl group on the second carbon and a morpholino group on the fourth carbon of the benzene ring, contributing to its unique chemical properties.
Uses
Used in Pharmaceutical and Agrochemical Industries:
2-METHYL-4-MORPHOLINO-6-NITROANILINE is utilized as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals, playing a crucial role in the development of new drugs and pesticides.
Used in Analytical Chemistry:
Due to its high water solubility, 2-METHYL-4-MORPHOLINO-6-NITROANILINE serves as a reagent for the determination of specific metal ions, aiding in accurate and efficient analytical processes.
Used in Dye and Pigment Development:
The unique chemical structure of 2-METHYL-4-MORPHOLINO-6-NITROANILINE lends itself to potential applications in the creation of dyes and pigments, offering novel colorants for various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 468741-20-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,6,8,7,4 and 1 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 468741-20:
(8*4)+(7*6)+(6*8)+(5*7)+(4*4)+(3*1)+(2*2)+(1*0)=180
180 % 10 = 0
So 468741-20-0 is a valid CAS Registry Number.
468741-20-0Relevant articles and documents
Discovery of a 1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity
Wittman, Mark,Carboni, Joan,Attar, Ricardo,Balasubramanian, Balu,Balimane, Praveen,Brassil, Patrick,Beaulieu, Francis,Chang, Chiehying,Clarke, Wendy,Dell, Janet,Eummer, Jeffrey,Frennesson, David,Gottardis, Marco,Greer, Ann,Hansel, Steven,Hurlburt, Warren,Jacobson, Bruce,Krishnananthan, Subramaniam,Lee, Francis Y.,Li, Aixin,Lin, Tai-An,Liu, Peiying,Ouellet, Carl,Sang, Xiaopeng,Saulnier, Mark G.,Stoffan, Karen,Sun, Yax,Velaparthi, Upender,Wong, Henry,Yang, Zheng,Zimmermann, Kurt,Zoeckler, Mary,Vyas, Dolatrai
, p. 5639 - 5643 (2007/10/03)
Compound 3 (BMS-536924), a novel small-molecule inhibitor of the insulin-like growth factor receptor kinase with equal potency against the insulin receptor is described. The in vitro and in vivo biological activity of this interesting compound is also rep
Novel tyrosine kinase inhibitors
-
Page 32, (2010/11/30)
The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase enzymes thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases which can be treated by inhibiting tyrosine kinase enzymes.